E
PDS Biotechnology Corporation PDSB
$0.77 $0.010.93% NASDAQ
Recommendation
Prev Close
$0.77
Volume
151,560
Avg Vol (90D)
677,638
Market Cap
$42.00M
Dividend & Yield
--
52-Week Range
$0.70 - $2.46
P/E (TTM)
--
EPS (TTM)
-$0.82
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
PDS Biotechnology announces request for Type C Meeting with FDA for PDS0101
12/2/2025 - TipRanks Financial Blog
PDS Biotechnology announces request for Type C Meeting with FDA for PDS0101
12/2/2025 - The Fly
PDS Biotech Announces Scheduling of Type C Meeting with U.S. Food and Drug Administration ( FDA )
12/2/2025 - Globe Newswire
PDS Biotechnology price target lowered to $3 from $5 at B. Riley
11/26/2025 - Yahoo! Finance: News
PDS Biotechnology price target lowered by $2 at B. Riley, here's why
11/25/2025 - The Fly
PDS Biotechnology (NASDAQ:PDSB) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
11/14/2025 - Ticker Report
PDS Biotechnology Corporation (NASDAQ:PDSB) Q3 2025 Earnings Call Transcript
11/14/2025 - Insider Monkey
PDS Biotechnology Corp (PDSB) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
11/13/2025 - GuruFocus
Q3 2025 PDS Biotechnology Corp Earnings Call Transcript
11/13/2025 - GuruFocus
PDS Biotechnology price target raised to $15 from $13 at H.C. Wainwright
11/13/2025 - TipRanks Financial Blog
PDS Biotechnology price target raised by $2 at H.C. Wainwright, here's why
11/13/2025 - The Fly
PDS Biotechnology Corporation (PDSB) Q3 2025 Earnings Call Transcript
11/13/2025 - Seeking Alpha: Transcripts
PDS Biotechnology Corporation (PDSB) Q3 2025 Earnings Call Transcript
11/13/2025 - SeekingAlpha
PDS Biotechnology GAAP EPS of -$0.19 beats by $0.01
11/13/2025 - SeekingAlpha.com: All News
PDS Biotechnology reports Q3 EPS (19c), consensus (20c)
11/13/2025 - The Fly
PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
11/13/2025 - Globe Newswire
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
11/11/2025 - GuruFocus
PDS Biotechnology announces up to $11.1M registered direct offering
11/11/2025 - TipRanks Financial Blog
PDS Biotechnology announces up to $11.1M registered direct offering
11/11/2025 - The Fly
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
11/11/2025 - Globe Newswire
PDS Biotechnology (PDSB) Reports Promising Immunotherapy Data at SITC 2025
11/10/2025 - GuruFocus
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical ...
11/10/2025 - GuruFocus
PDS Biotechnology announces data on activity of PDS0101, PDS01ADC
11/10/2025 - The Fly
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
11/10/2025 - Globe Newswire
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
11/6/2025 - Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$32.17M
EBIT (TTM)
-$32.23M
Net Income (TTM)
-$34.89M
Balance Sheet
Total Assets (Q)
$34.71M
Total Debt (Q)
$17.97M
Total Liabilities (Q)
$25.25M
Book Value Per Share (Q)
$0.1982
Cash Flow
Cash from Operations (TTM)
-$32.28M
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$8.73M
Net Change in Cash (TTM)
-$23.55M
Filings
Filing Date
Thursday, November 13, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 23 and 27 (est)
Price History
Loading...
Beta
2.04
7-Day Total Return
2.55%
30-Day Total Return
-20.13%
60-Day Total Return
-34.35%
90-Day Total Return
-34.35%
Year to Date Total Return
-55.22%
1-Year Total Return
-65.57%
2-Year Total Return
-85.33%
3-Year Total Return
-91.42%
5-Year Total Return
-63.11%
52-week Low
Dec 01, 2025 - $0.70
52-week High
Dec 04, 2024 - $2.46
Valuation
Market Cap
$42.00M - Nano Cap
Enterprise Value
$33.77M
Price/Sales (TTM)
--
Price/Book (Q)
3.87
Dividends and Shares
Shares Outstanding
46.87
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pdsbiotech.com
Phone Number
800 208 3343
Address
303A College Road East
Princeton, NJ 08540
Country
United States
Year Founded
2005
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company’s lead product candidate is Versamune HPV, which... more
NASDAQ 12/03/2025 12:08PM Eastern Quotes delayed